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Abstract
Background Management of anal fistula (AF) remains challenging with many controversies. The purpose of this study was 
to explore current surgical practice in the management of AF with a focus on technical variations among surgeons.
Methods An online survey was conducted by inviting all surgeons and physicians on the membership directory of European 
Society of Coloproctology and American Society of Colon and Rectal Surgeons. An invitation was extended to others via 
social media. The survey had 74 questions exploring diagnostic and surgical techniques.
Results In March 2018, 3572 physicians on membership directory were invited to take part in the study 510 of whom (14%) 
responded to the survey. Of these respondents, 492 (96%) were surgeons. Respondents were mostly colorectal surgeons (84%) 
at consultant level (84%), age ≥ 40 years (64%), practicing in academic (53%) or teaching (30%) hospitals, from the USA 
(36%) and Europe (34%). About 80% considered fistulotomy as the gold standard treatment for simple fistulas. Endorectal 
advancement flap was performed using partial- (42%) or full-thickness (44%) flaps. Up to 38% of surgeons performed liga-
tion of the intersphincteric fistula tract (LIFT) sometimes with technical variations. Geographic and demographic differences 
were found in both the diagnostic and therapeutic approaches to AF. Declared rates of recurrence and fecal incontinence 
with these techniques were variable and did not correlate with surgeons’ experience. Only 1–4% of surgeons were confident 
in performing the most novel sphincter-preserving techniques in patients with Crohn’s disease.
Conclusions Profound technical variations exist in surgical management of AF, making it difficult to reproduce and compare 
treatment outcomes among different centers.
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Introduction
Descriptions of anal fistula (AF) are found in the oldest 
known medical literature [1]. The reported incidence in 
four of the countries of the European Union ranges between 
10.4 per 100,000 in Spain and 23.2 per 100,000 in Italy [2]. 
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Common symptoms include pain, difficulty in sitting and 
discharge of pus/blood, and AF has a detrimental effect on 
quality of life that worsens in recurrent disease [3]. Although 
90–95% of cases are classified as cryptoglandular in origin, 
AF is a common and disabling phenotype of Crohn’s disease 
(CD) [4]. Indeed, one-third of CD patients will develop an 
AF, with just one-third of these achieving long-term heal-
ing [5].
From ancient times up to a few decades ago, treatment 
had remained unchanged, taking the form of a fistulotomy 
(“lay-open”) with knife or cautery, or the use of a seton. 
Despite the high healing rates [6, 7], impaired continence 
may result from fistulotomy, particularly in patients with 
high transsphincteric AF [8–10].
In an attempt to achieve the three main treatment goals 
(i.e., closure of the fistula, preservation of sphincter func-
tion, and minimization of healing time [11]), several sphinc-
ter-preserving techniques have been described alongside 
fistulotomy over the last 3 decades. These include endo-
rectal advancement flap (ERAF) [12], biomaterials (fibrin 
glue [13], fistula plugs [14, 15], adipose-derived stem cells 
[16]), ligation of the intersphincteric fistula tract (LIFT) 
[17], video-assisted anal fistula treatment (VAAFT) [18], 
fistula laser closure (FiLaC™) [19], and the over-the-scope 
clip  (OTSC®) Proctology system [20].
While fistulotomy is still regarded by many as the gold 
standard treatment for low-lying AF, questions remain about 
how to tailor available surgical options to more complex 
cases.
Several guidelines are available worldwide for the diag-
nosis and treatment of AF (cryptoglandular or related to CD) 
[4, 21–33], but many recommendations are controversial 
or lack high-quality evidence [34], thus making treatment 
decisions extremely challenging in the majority of complex 
cases.
The aim of this study was to explore the contemporary 
management of cryptoglandular AF, and to obtain a snap-
shot of the current approaches from surgeons worldwide. 
Secondary aims were to investigate current surgical options 
in CD-related AF, and to inform the generation of a surgical 
treatment algorithm for the various types of AF.
Materials and methods
All members of the American Society of Colon and Rectal 
Surgeons (ASCRS) and European Society of Coloproctol-
ogy (ESCP) were identified through membership directo-
ries (ASCRS, n = 3126; ESCP, n = 415) and were invited by 
an email to join a fully anonymous online survey (further 
details provided below). A link to the survey was dissemi-
nated via social media (i.e., Twitter and LinkedIn) to capture 
further potential respondents. A total of four further email 
reminders (as per software restrictions) were sent throughout 
the period of online availability of the survey. This study 
was exempt from review board approval at our institutions.
Survey
The survey (namely International Survey on Technical 
Aspects of Anal Fistula Surgery) consisting of a 74-item 
questionnaire was designed and developed by the first 
authors (CR & UG) using an online platform [“Online sur-
veys” (formerly BOS—Bristol Online Survey), developed 
by the University of Bristol]. Co-authors piloted the survey, 
assessed the design and checked the feasibility and validity 
of the questions. The finalized online survey was made avail-
able online from March 5th to May 28th 2018. The Checklist 
for Reporting Results of Internet E-Surveys (the CHERRIES 
statement [35]) is provided as a supplementary file.
The survey aimed to assess crucial elements in surgeons’ 
evaluation and treatment of perianal abscess and AF, and to 
capture key demographic information about the respondents. 
The latter included gender, age group, surgeon’s region of 
practice and type of hospital (i.e., academic, non-academic 
teaching, or non-teaching), membership in colorectal socie-
ties, regular involvement in research, training level, years 
of professional experience, and grade of personal experi-
ence in AF management during the last year. Other ques-
tions assessed the use and usefulness of diagnostic modali-
ties [i.e., endoanal ultrasound (EAUS); magnetic resonance 
imaging (MRI), computed tomography (CT), and fistulog-
raphy] in initial workup and guiding treatment strategies for 
both cryptoglandular and CD-related AF. Incision and drain-
age of perianal abscess and seton placement were assessed 
with questions covering preference of site of incision with 
respect to abscess location, and seton type (i.e., cutting, 
loose, medicated) and material(s). Surgeons’ views on fis-
tulotomy and fistulectomy were investigated with questions 
covering the amount of external anal sphincter (EAS) they 
would safely sacrifice in patients with transsphincteric AF 
(further delineated with respect to gender), and the possibil-
ity of a simultaneous sphincter reconstruction. The use of 
contemporary sphincter-preserving surgical strategies was 
also explored, collecting the following data for each tech-
nique: number of procedures performed yearly, type(s) of 
AF in which the technique is considered appropriate, and 
how the fistula tract is managed. Lastly, participants were 
asked to declare their rate of recurrence, minor and major 
fecal incontinence with each technique and separately for 
cryptoglandular and CD-related AF.
All questions were set as mandatory fields with real-time 
validation and automated skip logic to prevent missing data 
and avoid illogical or incompatible responses. Quantitative 
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data were automatically collected by the software and 
exported to a Microsoft Excel spreadsheet.
Statistical analysis
Categorical variables across groups were compared using 
Fisher’s exact test or Pearson’s Chi-square test; 95% confi-
dence intervals (CI) for proportions were calculated using 
the Wilson method with continuity correction. Binary and 
ordinal logistic regression models were also fitted to assess 
the association between surgeons’ preferences and their 
demographics and experience. The denominator of the per-
centages of respondents is the total number of colorectal sur-
geons who took part (n = 492). All analyses were performed 
in STATA 15 (StataCorp LLC, College Station, TX, USA).
Results
A total of 3708 individuals were approached by email via 
membership directories of the two above-mentioned colo-
rectal societies (n = 3541) and via social media invitation 
(n = 167). There were 3572 (96.3%) appropriate recipients, 
excluding 136 email addresses listed incorrectly or recog-
nized as spam or with invalid domains.
Demographics
In total, 510/3572 (14.3%) responded to the survey. Of these, 
492 (96%) were surgeons and contributed to the main results 
(surgical techniques and treatment outcomes). A total of 
194 (39%) and 48 (10%) surgeons came from North and 
South Americas, respectively, 170 (35%) from Europe, 57 
(12%) from Asia, 17 (3%) from Australia and New Zealand, 
and only 2 (0.4%) from Africa, for a total of 66 countries 
involved (Suppl. Figure 1). Respondents were mostly men 
(82%), ≥ 40 years of age (64%), colorectal surgeons (84%) 
at consultant level (84%), practicing in academic (53%) or 
non-academic teaching (30%) hospitals (Table 1).
Diagnostics in cryptoglandular and CD‑related AF
There was strong disagreement among surgeons about the 
usefulness of endoanal ultrasound (EAUS) in the initial 
assessment of AF, with only one-third of them finding this 
test extremely useful in both cryptoglandular and CD-related 
AF. On the other hand, a significant proportion (nearly 30%) 
of respondents rated EAUS as not at all useful in any type 
of fistula (Fig. 1). Americans were much more skeptical 
than Europeans on the usefulness of EAUS in both cryp-
toglandular (OR 0.21; p < 0.0001) and CD-related AF (OR 
0.27; p < 0.0001) (Suppl. Table 1). A similar skepticism was 
Table 1  Surgeons’ demographics and experience
N (%)
Geographic distribution
 North America 194 (39)
 South America 48 (10)
 Europe 170 (35)
 Asia 57 (12)
 Australia and New Zealand 17 (3)
 Africa 2 (< 1)
Gender
 Males 401 (82)
 Females 91 (18)
Age group (years)
 < 30 2 (< 1)
 30–39 125 (25)
 40–49 149 (30)
 50–59 129 (26)
 ≥ 60 87 (18)
Specialty
 Colorectal surgery 414 (84)
 General surgery 78 (16)
Training level
 Consultant 412 (84)
 Fellow 55 (11)
 Resident 25 (5)
Type of hospital
 Academic 260 (53)
 Non-academic teaching 147 (30)
 Non-teaching 85 (17)
Participate in  researcha
 Local investigator initiated 409 (83)
 Multicenter 184 (37)
 Industry sponsored 93 (19)
Membership in scientific  societiesa
 ASCRS 304 (62)
  No. of Americans (% total American respondents) 228/242 (94)
 ESCP 161 (33)
  No. of Europeans (% total European respondents) 119/170 (70)
 ACPGBI 43 (9)
 Othersb 130 (26)
 None 8 (2)
Professional experience with AF management (years)
 > 20 167 (34)
 11–20 124 (25)
 6–10 124 (25)
 0–5 77 (16)
Personal experience in the last year (no. total cases)
 > 50 104 (21)
 41–50 45 (9)
 31–40 55 (11)
 21–30 123 (25)
 11–20 117 (24)
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evident from surgeons working in non-teaching compared to 
academic hospitals (Table 2).
Most surgeons rated magnetic resonance imaging (MRI) 
as extremely useful in the diagnostic workup of cryptoglan-
dular (75%) and CD-related (60%) AF, with only a minority 
(6%) finding this test ‘not at all useful’. However, compared 
to Europeans, Americans were less likely to score this test 
as extremely useful, especially for CD-related AF (OR 0.32; 
95% CI 0.19–0.55; p < 0.0001; Table 2 and Suppl. Table 1). 
Compared to those under 40, surgeons between 50 and 
59 years of age were more convinced about the usefulness of 
MRI in CD (OR 3.11; p = 0.043), which also positively cor-
related to the grade of surgeons’ experience, both in terms 
of number of cases per year and training level (Table 2).
Most surgeons rated computed tomography scanning and 
fistulography as not at all useful in both cryptoglandular 
(62% and 72%, respectively) and CD-related (73% and 68%, 
respectively) AF. Among the 6% of surgeons rating fistulog-
raphy as extremely useful, most were Americans (Suppl. 
Table 1). Moreover, this subgroup comprised less experi-
enced surgeons from non-teaching centers.
The main reasons cited by respondents for the prefer-
ences in imaging modality were (a) demonstrated higher 
accuracy over other modalities (74% of respondents); (b) 
limited personal expertise with other modalities (20%); (c) 
lack of availability of other modalities (11%); examination 
under anesthesia (EUA) preferred over diagnostic tests (5%).
Compared to MRI, EAUS was globally less available 
(96% vs. 76% of surgeons’ working centers, respectively). 
However, only 56% of surgeons stated that they would per-
sonally perform the test. Of these, 62% routinely used three-
dimensional (3-D) EAUS and 91% found the injection of 
hydrogen peroxide into the external orifice helpful during 
the test.
Among surgeons using MRI preoperatively, the main 
indications were recurrent (88%) and primary (49%) com-
plex AF, and recurrent simple AF (32%). Similarly, among 
EAUS users, the main indications were recurrent (37%) and 
primary (35%) complex AF, and recurrent simple AF (23%).
Only a minority of surgeons stated that they would use 
MRI (5%) and EAUS (15%) for any type of AF.
More than half (57%) of respondents would arrange 
an emergency EUA without any preoperative imaging in 
patients presenting with a perianal abscess, and 18% also in 
case of primary simple fistula. Similarly, a significant pro-
portion of surgeons would arrange an elective EUA without 
any preoperative imaging in patients presenting with pri-
mary simple fistula (53%) or anal abscess (32%).
How to drain an abscess
Patient position and setting
Overall, 62% of surgeons preferred to drain a perianal 
abscess with the patient in lithotomy position, followed by 
prone jack-knife (34%) and Sims (4%) positions. Americans 
AF anal fistula, CD Crohn’s disease, ASCRS American Society of 
Colon and Rectal Surgeons, ESCP European Society of Coloproctol-
ogy, ACPGBI Association of Coloproctology of Great Britain and 
Ireland
a Multiple answer question
b Included 37 further surgical societies worldwide
Table 1  (continued)
N (%)
 1–10 45 (9)
 None 3 (1)
Personal experience in the last year (no. CD-related AF)
 > 30 32 (7)
 21–30 12 (2)
 11–20 67 (14)
 6–10 108 (22)
 1–5 207 (42)
 None 66 (13)
Fig. 1  Usefulness ratings of diagnostic modalities in patients with anal fistula (a cryptoglandular; b Crohn’s disease related). MRI magnetic reso-
nance imaging, EAUS endoanal ultrasound, CT computed tomography
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were less likely compared to Europeans to prefer lithotomy 
position (OR 0.07, CI 0.04–0.13; p < 0.0001).
Over half of respondents (59%) would perform incision 
and drainage both in the operating room (OR) and the outpa-
tient clinic, while 41% would exclusively do this in the OR.
Technique (Fig. 2)
The identification of an internal orifice at the time of abscess 
drainage was more likely deemed ‘necessary’ by older sur-
geons than by those under 40 years of age (OR 2.28, CI 
1.31–3.93; p = 0.003).
Slightly over one in four (28%) surgeons would always 
place a seton if an internal opening and tract were found 
during incision and drainage (I&D), while one in six (16%) 
would never consider this option. A large proportion of 
respondents would place a seton only in selected cases, 
depending on the characteristics and location of the abscess 
[e.g., horseshoe ischioanal abscess (38%)].
When inquired about the preferred site of abscess drain-
age, most surgeons drained intersphincteric (36%) or pel-
virectal (31%) abscesses ‘inwards’ (into the rectum/anus) 
while 27% would never consider this option. Conversely, 
over half of the surgeons drained ischioanal or any horseshoe 
abscess (59%) ‘outwards’ (through the perineal skin), while 
27% would consider this option also for intersphincteric 
abscess, and 33% did so in all cases.
Over a half of the respondents (55%) might consider 
using a small latex catheter (e.g., Petzer) for I&D of perianal 
abscess, mainly in patients presenting with deep abscesses 
(82%).
Setons
Type and material
The majority of respondents reported using loose setons 
(90%), with fewer utilizing cutting (31%) or medicated 
(3%) setons. Those using a cutting seton (n = 153) reported 
a median tightening interval of 2 (interquartile range 2–4) 
weeks. Most surgeons in this group came from the Ameri-
cas (OR 3.19, CI 1.92–5.31; p < 0.0001) and the rest of 
the world (OR 3.10, CI 1.63–5.88; p = 0.001) rather than 
Europe (Suppl. Table 1). With regard to seton material, ves-
sel loop (silicone) was the most utilized (72%), followed by 
silk (23%), rubber band (11%), and Prolene (10%) (Suppl. 
Figure 2). Only six (1%) surgeons stated that they would 
never use a seton.
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Scope
Most surgeons (77%) considered the use of setons as part 
of a staged surgical approach. In this scenario, they would 
leave the seton in situ for a median of 8 (interquartile range 
6–12) weeks to establish a fistula tract before attempting any 
further definitive treatments. Overall, 70% of surgeons may 
consider using a seton as a therapeutic strategy in its own 
right (i.e., palliative loose seton; excl. cutting seton), with 
over a half (60%) of them considering this option in patients 
with complex perianal CD.
Surgical techniques
Surgeons’ experience with the currently available surgical 
techniques mirrored their chronological development, with 
the newest approaches (i.e., VAAFT, FiLaC, and OTSC) 
being performed by less than 10% of the respondents 
(Fig. 3).
Fistulotomy and fistulectomy
Fistulotomy and fistulectomy were the most frequently 
performed operations, with over 40% of respondents car-
rying out > 20 procedures per year (Fig. 3). Overall, 82% 
of surgeons considered fistulotomy as the gold standard 
treatment for simple fistula only, and 13% for most AF. 
In the latter group, Europeans and surgeons practicing in 
non-teaching hospitals more commonly used this approach 
compared to Americans [OR 2.38, 95% confidence interval 
(CI) 1.18–4.79; p = 0.015] and surgeons from academic cent-
ers (OR 2.31; 95% CI 1.13–4.49; p = 0.021), respectively. 
Fig. 2  Surgeons’ attitudes 
towards incision and drainage 
(I&D) of perianal abscess. NB: 
multi-answer questions—per-
centage of respondents who 
selected each answer option 
(e.g., 100% would represent that 
all these question’s respondents 
chose that option)
Fig. 3  Number of cases per 
year according to each surgical 
technique. ERAF endorectal 
advancement flap, LIFT ligation 
of the intersphincteric fistula 
tract, VAAFT video-assisted 
anal fistula treatment, FiLaC 
fistula laser closure, OTSC over-
the-scope clip
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During fistulotomy for transsphincteric fistula, in the absence 
of pre-existing incontinence, surgeons would safely sacrifice 
up to a median of 25% (interquartile range 16–30%) of the 
external anal sphincter, with 21% of respondents making 
no gender distinction. Conversely, a significant proportion 
(51%) of surgeons would never cut the external sphincter in 
females with anterior fistula, while another 22% surgeons 
would never cut at all in female patients.
Less than half of the respondents routinely performed 
either marsupialization or immediate sphincter reconstruc-
tion (primary sphincteroplasty) after fistulotomy for inter-
sphincteric (32% and 9%, respectively) and transsphincteric 
fistulas (24% and 19%).
One in four surgeons considered fistulectomy an adjunct 
to sphincter-preserving procedures. Conversely, 15% found 
this technique a therapeutic strategy in its own right, while 
another 20% agreed with both uses.
ERAF
Almost four in five surgeons declared they had some form 
of experience with ERAF. However, slightly less than 
15% of respondents performed > 10 procedures per year 
(Fig. 3). When asked about the complexity of the opera-
tion, more than half (51%) of the respondents found ERAF 
technically demanding. ERAF was the preferred treat-
ment option for primary AF previously treated with seton 
(64%) and recurrent AF (70%) (Fig. 4). Seven percent of 
respondents used ERAF for other indications such as ante-
rior location in females and rectovaginal fistula. Partial 
(only mucosa–submucosa) or full-thickness (including the 
internal sphincter) ERAF was equally fashioned (53% and 
52% of respondents, respectively), compared to anodermal 
ERAF, which was performed by only 17% of respondents. 
In addition to ERAF, curettage was the preferred method of 
treatment of the fistula tract (65%), followed by fistulectomy 
(core-out; 43%). Only a minority of surgeons (17%) opted 
for concomitant additional procedures (e.g., VAAFT; plugs; 
glue).
Plugs
Almost one in four surgeons declared experience with plug 
insertion, with < 3% of respondents overall performing > 10 
of these procedures per year (Fig. 3).  Surgisis® AFP™ was 
the most used plug (71%) among the 130/492 surgeons 
familiar with this technique (Suppl. Figure 3). Before plug 
insertion, curettage with brush was the preferred method of 
treatment of the fistula tract (77%), followed by irrigation 
with saline (39%) or hydrogen peroxide (35%), and curet-
tage with spoon (31%). More than half (59%) of respondents 
reported placing a seton prior to plug insertion in all cases.
Glue and paste injection
Less than 15% of surgeons had experience of using glue 
and paste injection, with only 6/492 (1%) performing > 10 
of these procedures per year (Fig. 3). Almost half of the 
respondents (48%) suggested this treatment option for 
Fig. 4  Recommended surgical techniques according to anal fistula type. Bars indicate 95% confidence intervals. ERAF endorectal advancement 
flap, VAAFT video-assisted anal fistula treatment, FiLaC fistula laser closure, OTSC over-the-scope clip
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recurrent AF (Fig. 4). Fibrin glue was the most used infill 
material (68%) (Suppl. Figure 4). Four in five surgeons usu-
ally close the internal opening of the fistula tract after glue/
paste injection, using either sutures (84%) or ERAF (36%). 
Curettage, either with a brush (59%) or spoon (44%), was the 
preferred method to manage the fistula tract before injection. 
Compared to those considering glue/paste as a therapeutic 
strategy in its own right (45%), a higher proportion of sur-
geons judged this option to be an adjunct to other sphincter-
preserving procedures (55%).
Ligation of the intersphincteric fistula tract (LIFT)
Almost three in four surgeons had experience of performing 
LIFT. However, only 14% of respondents performed > 10 
procedures per year (Fig. 3). When asked about potential 
contraindications to LIFT, intersphincteric AF (56%) and 
rectovaginal fistula (50%) were the most common answers. 
According to 44% of respondents, fistula level was not a 
determinant of the choice to perform a LIFT, whilst 32% and 
19% felt that high and low AF, respectively, may preclude 
this treatment option.
A significant proportion of surgeons (31%) performed 
technical variations of the original technique, all listed in 
Suppl. Figure 5. Of note, fellows or residents were much 
less likely to add distal fistulectomy compared to surgeons 
at consultant level (OR 0.21, CI 0.07–0.66; p = 0.007).
VAAFT
Less than 10% of surgeons have used VAAFT, with only 3% 
overall performing > 10 procedures per year (Fig. 3). The 
technique was suggested for recurrent AF (62%), AF previ-
ously treated with seton (41%) or not (31%) (Fig. 4). One in 
five surgeons recommended VAAFT also for AF with con-
comitant abscess. The vast majority of respondents (85%) 
closed the internal opening after VAAFT. This was generally 
performed using suture (61%) or ERAF (55%). A minority 
of surgeons used endostapler (18%) or other devices (e.g., 
OTSC). The majority of respondents (77%) managed the 
fistula tract with curettage with brush after VAAFT.
FiLaC
Overall, 10% of surgeons have used FiLaC, with only 2% of 
these performing > 10 procedures per year (Fig. 3). FiLaC 
was the preferred technique to treat AF with no previous 
seton (Fig. 4). The technique was used as the only treat-
ment option for any type of fistula by 8% of surgeons. Probe 
withdrawal speed and energy varied among respondents; 
however, 1 cm per 3 s and 12 W were the most used settings 
(47% and 38%, respectively). The majority of surgeons 
(78%) closed the internal opening after FiLaC, with suture 
(84%).
OTSC
OTSC was the least used technique, with only 3 (1%) of the 
surgeons interviewed performing > 10 procedures per year 
(Fig. 3). The main indications were recurrent AF and AF 
with previous seton (both 56%).
Recurrence and incontinence rates
A significant proportion of respondents stated their own 
recurrence rate was 5% or below after fistulotomy (61%), 
fistulectomy (29%), and therapeutic seton (29%) for cryp-
toglandular AF (Suppl. Figure 6). Recurrence rates varied 
broadly with sphincter-preserving techniques for cyptoglan-
dular AF and with any techniques for CD-related AF. Only 
9% and 4% of respondents derived these rates from their 
own published work in cryptoglandular and CD-related AF, 
respectively. Almost all respondents (97%) were familiar 
with seton placement in CD-related AF. Except for fistul-
otomy (49%), experience with other techniques was very 
limited (Suppl. Figure 7).
Declared rates of minor and major fecal incontinence 
were globally low, with better outcomes after sphincter-
preserving procedures compared to fistulotomy (Suppl. 
Figure 8). However, only 4% of surgeons derived such rates 
from their own published work. Furthermore, less than half 
of respondents (42%) regularly used validated question-
naires, whilst 11% of them did not routinely assess inconti-
nence preoperatively. Compared to Europeans and Ameri-
cans, surgeons from the rest of the world were less likely 
to use validated questionnaires (OR 0.54, CI 0.31–0.96; 
p = 0.036) as well as those practicing in non-academic teach-
ing (OR 0.61, CI 0.40–0.94; p = 0.025) and non-teaching 
hospitals (OR 0.52, CI 0.30–0.88; p = 0.016) compared to 
those from academic centers.
Recurrence and incontinence rates with any surgical tech-
niques did not correlate with surgeons’ experience expressed 
as number of cases per year or number of years of practice.
Discussion
Key results
This is the first study to examine the approach to AF of 
surgeons worldwide. The survey highlighted lack of consen-
sus regarding the optimal management strategy of patients 
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with AF, demonstrating profound intra- and inter-procedural 
variations across the various geographic regions and partici-
pants’ level of expertise.
Limitations
This survey provides data from a large number of surgeons 
worldwide. However, there are a number of limitations 
worthy of mention. First, the response rate was low (14%). 
Online surveys do confer several advantages, not least being 
cost-effective but also reaching people worldwide and allow-
ing prompt and accurate data collection. However, when 
physicians are asked to take part, they respond poorly and it 
is common that the response rate is below 20% [36].
Several software restrictions may have negatively affected 
the response rate. The online surveys email tool did not 
allow personalized correspondence (known to improve 
response rate [37]) nor reported bounced emails; if any 
respondent replied to the email they received from online 
surveys this was automatically discarded and did not reach 
survey authors or the support team; a maximum of one invi-
tation email and four reminder emails per respondent (five 
in total) were sent.
Although we aimed to approach practicing colorectal 
surgeons (primarily members of two of the most renowned 
coloproctology societies in the world), the data obtained may 
not reflect expertise focused on fistula management. Despite 
the survey being launched worldwide including on social 
media, it did not reach surgeons, or at least obtain significant 
response from them in areas such as the Asia-Pacific region 
and Africa, compared to those in the Americas and Europe, 
nor did we approach national or reginal coloproctology soci-
eties outside of Europe and the Americas. As the question-
naire was designed by surgeons from Europe, the questions 
may not have adequately represented the views of surgeons 
from other parts of the world, which may have dissuaded 
some surgeons from these regions from taking part.
Interpretation
Management of AF remains challenging, with continuously 
emerging surgical techniques hampering the development of 
a robust treatment algorithm. To complicate matters further, 
the quality of publications is variable in the literature, with 
many studies having limited follow-up or being too small in 
size for robust assessment of clinical endpoints [21]. Hetero-
geneity in outcome measures hampers meta-analysis. Con-
troversies in the published guidelines can be partly explained 
by the fact that some of them have become outdated because 
new medical and surgical therapies have been introduced 
[34]. Moreover, geographic differences also exist.
Among the imaging modalities used to assess AF, our 
data confirm that most surgeons consider fistulography 
superseded by other techniques, in line with the second 
ACPGBI position statement [21], while a minority (mostly 
Americans) still proclaim its usefulness, in line with the 
ASCRS Clinical Practice Guidelines [22]. Despite EAUS 
having an established role in the assessment of AF [21], 
a significant proportion (nearly 30%) of respondents rated 
this test as ‘not at all useful’ in any type of fistula. Inter-
estingly, compared to Europeans and those who worked in 
academic centers, American respondents and surgeons from 
non-teaching hospitals were much more skeptical of the 
usefulness of EAUS in the initial assessment of both cryp-
toglandular and CD-related AF. This may be partly due to 
limited local availability of EAUS compared to MRI among 
interviewed surgeons.
There is a proportion of patients who have an internal 
opening at the time of incision and drainage. Although a 
randomized clinical trial demonstrated this finding in 83% 
of patients, AF does not develop in all cases [38]. The iden-
tification of an internal orifice at the time of abscess drain-
age was more likely deemed ‘necessary’ by older surgeons 
compared to those under 40 years old of age. Sahnan et al. 
support this finding [39] in selected cases, suggesting that 
seton placement might be considered in high-risk individu-
als (e.g., recurrent abscesses) as long as it was performed by 
an experienced colorectal surgeon, without whom (e.g., out 
of hours procedure) a simple I&D may suffice.
The vast majority of surgeons (82%) considered fistul-
otomy the gold standard of treatment for simple fistula. On 
the other hand, a significant proportion (51%) of surgeons 
would never cut the external sphincter in females with ante-
rior fistula, while another 22% surgeons would never cut 
any muscle at all in female patients. This is in line with 
the ACPGBI recommendation that fistulotomy results in a 
reliable cure with good patient satisfaction, where 2 cm of 
proximal muscle remains intact [21].
Our data showed that sphincter-sparing techniques are 
still in their infancy, with an overall limited level of exper-
tise among interviewed surgeons. About one-third (31%) of 
respondents performed technical variations of the original 
LIFT procedure [17], with distal fistulectomy being the most 
prevalent (Suppl. Figure 5), although this was described in 
the first description of intersphincteric fistula division in 
1993 [40]. LIFT plus distal fistulectomy has been shown to 
correlate with high healing rates in the mid-term [41] and 
was more likely performed by surgeons at consultant level 
compared to fellows or residents.
In conclusion, this survey showed several procedural vari-
ations with all the commonly adopted surgical techniques 
for AF, which are likely to significantly bias the outcomes 
of published studies and hamper meta-analysis. In addition 
to patient selection, a meticulous description of all surgical 
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steps should be compulsory for any future scientific contri-
bution on this topic to allow reproducibility and compari-
son of outcomes among centers. Furthermore, technologi-
cal innovations should be reported in accordance with the 
IDEAL collaboration guidelines [42] and application of the 
core outcome set (COS) should be strongly encouraged to 
reduce heterogeneity in outcome reporting for CD-related 
AF [43]. The core outcome set has not been established for 
cryptoglandular AF yet and it will require a similar rigorous 
process as the work done for CD-related AF.
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